BOM/543904 (BOM/543904)

Bombay Stock Exchange: BOM/543904 · INR

₹2,484

-17.00 (-0.7%)· Recorded snapshot

Market cap	1T
Revenue (ttm)	153.8B
Net income (ttm)	22.4B
EPS (ttm)	₹54.2
P/E (trailing)	45.8x
P/E (forward)	38.3x
Volume	25,609

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 153.8B
Net income (ttm): 22.4B
EPS (ttm): ₹54.2
P/E (trailing): 45.8x
P/E (forward): 38.3x
Market cap: 1T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E38.3

P25 n/aP50 n/aP75 n/a

Trailing P/E45.8

P25 n/aP50 n/aP75 n/a

ROE13.6

P25 n/aP50 n/aP75 n/a

ROIC12.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BOM/543904 indicators

Market & fundamental data

Available fields

224

Groups with data

Currency

INR

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-10-26
Employees	20,451
Employees change	831
Employees growth	4.24%
Enterprise value	INR 1.1T
Exchange	Bombay Stock Exchange
Financial currency	INR
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	March
Founded	1991
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	INE634S01028
Last earnings date	2026-10-26
Last refreshed	2026-10-28
Market cap	INR 1T
Next earnings date	2026-11-03
Price	INR 2,483.60
Price currency	INR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bom/543904
Website	https://www.mankindpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	43.72x
Average P/E ratio (3Y)	49.47x
Average P/E ratio (5Y)	49.01x
Earnings yield	2.18%
EV/Earnings	47.44x
EV/EBIT	32.52x
EV/EBITDA	25.76x
EV/FCF	41.91x
EV/Sales	6.92x
FCF / EV yield	2.39%
FCF yield	2.46%
Forward P/E	38.35x
Graham number	726.15037
Graham upside	-70.96%
Industry forward P/E	33.04x
Industry P/E	38.82x
Lynch fair value	INR 701.06
Lynch upside	-71.96%
P/(FCF - SBC) ratio	41x
P/(OCF - SBC) ratio	31.46x
P/B ratio	5.79x
P/E ratio	45.79x
P/FCF ratio	40.71x
P/OCF ratio	31.29x
P/S ratio	6.72x
Price / tangible book value	58.55x
Price/EBITDA ratio	25.28x
Sector forward P/E	36.12x
Sector P/E	45.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	21.18%
EBITDA margin	26.59%
Effective tax rate	21.04%
FCF margin	16.51%
Gross margin	71.05%
Operating margin	21.18%
Pretax margin	18.64%
Profit margin	14.58%
Profit per employee	INR 1.1M
Profitable quarters	19
Profitable years	8
Revenue per employee	INR 7.5M
ROA	7.05%
ROA (5Y)	10.38%
ROCE	14.12%
ROE	13.56%
ROE (5Y)	19.29%
ROIC	12.46%
ROIC (5Y)	20.77%
SBC / revenue	0.11%
Tax / revenue	3.92%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	27.25%
EPS growth (Q)	38.93%
EPS growth (QoQ)	25.18%
EPS growth 3Y	11.76%
EPS growth quarters	4
EPS growth years	0
FCF growth	7.92%
FCF growth 3Y	18.32%
Gross profit growth	15.6%
Gross profit growth (Q)	18.92%
Gross profit growth 3Y	19.87%
Net income growth	28.09%
Net income growth (Q)	39.09%
Net income growth (QoQ)	25.25%
Net income growth 3Y	12.92%
Net income growth quarters	4
Net income growth years	0
OCF growth	14.94%
OCF growth 3Y	16.96%
Operating income growth	34.66%
Operating income growth (Q)	33.74%
Operating income growth 3Y	19.89%
Revenue growth	13.53%
Revenue growth (Q)	17.33%
Revenue growth (QoQ)	7.62%
Revenue growth 3Y	17.71%
Revenue growth quarters	15
Revenue growth years	7

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -7.6B
Depreciation and amortization	INR 8.3B
EBIT	INR 32.6B
EBITDA	INR 40.9B
EPS	INR 54.24
Financing cash flow	INR -35.2B
Free cash flow	INR 25.4B
Free cash flow minus SBC	INR 25.2B
Gross profit	INR 109.3B
Income taxes	INR 6B
Investing cash flow	INR 9.9B
Net borrowing	INR -29.1B
Net cash flow	INR 7.9B
Net income	INR 22.4B
Operating cash flow minus SBC	INR 32.9B
Operating income	INR 32.6B
Revenue	INR 153.8B
Stock-based compensation	INR 176.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 425.79
Debt / EBITDA	1.32
Debt / equity	0.3
Debt / FCF	2.14
Goodwill	INR 64.9B
Interest coverage	6.41
Long-term assets	INR 210B
Long-term liabilities	INR 52.1B
Net cash (debt)	INR -27.6B
Net cash / market cap	-2.67%
Net debt / EBITDA	0.68
Net debt / equity	0.15
Net debt / FCF	1.09
Piotroski F-Score	7
Property, plant and equipment	INR 37.9B
Shareholders' equity	INR 178.6B
Tangible book value	INR 17.7B
Tangible book value per share	INR 42.75
Total assets	INR 289.5B
Total cash	INR 26.6B
Total debt	INR 54.2B
Total liabilities	INR 111B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.53
Current assets	INR 79.6B
Current liabilities	INR 58.8B
Current ratio	1.35
Inventory turnover	2.06
Net working capital	INR 17.3B
Quick ratio	0.82
Working capital	INR 20.7B
Working capital turnover	9.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.67%
Dividend growth years	0
Dividend payment date	2025-08-30
Dividend payment years	1
Dividend per share	INR 0.00
Last dividend	INR 1.00
Shareholder yield	-0.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	INR 2,367.23
1D price change	-0.68%
1M price change	1.02%
1M total return	1.02%
1W price change	9.63%
1W total return	9.63%
1Y price change	3.55%
1Y return CAGR	3.55%
1Y total return	3.55%
20-day SMA	INR 2,392.26
200-day SMA	INR 2,310.47
3M price change	-1.98%
3M total return	-1.98%
3Y price change	42.47%
3Y return CAGR	12.53%
3Y total return	42.52%
50-day SMA	INR 2,377.27
50-day SMA vs 200-day SMA	50over200
52-week high	INR 2,640.30
52-week high date	2026-07-29
52-week low	INR 1,909.90
52-week low date	2026-03-23
6M price change	10.35%
6M total return	10.35%
All-time high	INR 3,050.00
All-time high date	2024-12-23
All-time low	INR 1,240.75
All-time low date	2023-05-22
Average true range (ATR)	INR 80.78
Average volume	68.3K
Change from 52-week high	-5.93%
Change from 52-week low	30.04%
Change from all-time high	-18.01%
Change from all-time low	101.54%
Change from open	-0.66%
Day's gap	-0.02%
Dollar volume	INR 63.6M
High price	INR 2,549.40
Low price	INR 2,479.10
Monthly RSI	56.59
Open price	INR 2,500.00
Position in 52-week range	6.4%
Previous close	INR 2,500.60
Price vs 150-day SMA	5.63%
Price vs 20-day SMA	4.53%
Price vs 200-day SMA	8.23%
Price vs 50-day SMA	5.19%
Relative volume	0.37
RSI	58.68
Sharpe ratio	0.04
Sharpe ratio (3Y)	0.39
Sortino ratio	0.28
Sortino ratio (3Y)	0.82
Volume	25.6K
Weekly RSI	56.34
YTD price change	13.85%
YTD total return	13.85%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	113.1M
Shares change (QoQ)	0.05%
Shares change (YoY)	0.67%
Shares held by insiders	57.67%
Shares held by institutions	20.71%

Deeper analysis on BOM/543904

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BOM/543904 report

Is a complete BOM/543904 research report available?

No complete published report is available for bom/543904 (BOM/543904) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BOM/543904 (BOM/543904)

Price

Financial snapshot

Fair-value bridge

Latest news · BOM/543904

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOM/543904 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BOM/543904

Frequently asked questions